Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Type I Interferon Excess in Autoimmune Diseases and Genetic Type I Interferonopathies

NCT07837986 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.

NCT NCT07837986
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07837986 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Type I Interferon Excess in Autoimmune Diseases and Genetic Type I Interferonopathies
Lead sponsor
Hospices Civils de Lyon
Phase
Not applicable
Overall status
Not yet recruiting
Start date
December 1, 2026
Completion date
January 1, 2033
Enrollment
120 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

connective tissue diseases, inflammatory myopathies, systememic lupus erythematosus, systemic sclerosis (ssc), type 1 interferonopathies